These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10990126)

  • 1. Efficacy and practicability of inhaled nitric oxide and aerosolized prostaglandins.
    Booke M; Hinder F
    Intensive Care Med; 2000 Jul; 26(7):1015-6. PubMed ID: 10990126
    [No Abstract]   [Full Text] [Related]  

  • 2. Unsuccessful treatment of pulmonary hypertension by inhaled nitric oxide and aerosolized prostacyclin.
    Tibballs J; Goh TH; McKenzie I; Hochmann M
    Anaesth Intensive Care; 1999 Jun; 27(3):316-7. PubMed ID: 10389572
    [No Abstract]   [Full Text] [Related]  

  • 3. Unsuccessful treatment of pulmonary hypertension by inhaled nitric oxide and aerosolized prostacyclin.
    Barry PW
    Anaesth Intensive Care; 1999 Dec; 27(6):670-1. PubMed ID: 10631434
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.
    Haraldsson A; Kieler-Jensen N; Nathorst-Westfelt U; Bergh CH; Ricksten SE
    Chest; 1998 Sep; 114(3):780-6. PubMed ID: 9743166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aerosolized prostacyclins.
    Siobal M
    Respir Care; 2004 Jun; 49(6):640-52. PubMed ID: 15165299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aerosolized prostacyclin versus inhaled nitric oxide in children with severe acute respiratory distress syndrome.
    Pappert D; Busch T; Gerlach H; Lewandowski K; Radermacher P; Rossaint R
    Anesthesiology; 1995 Jun; 82(6):1507-11. PubMed ID: 7793662
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group.
    Hoeper MM; Olschewski H; Ghofrani HA; Wilkens H; Winkler J; Borst MM; Niedermeyer J; Fabel H; Seeger W
    J Am Coll Cardiol; 2000 Jan; 35(1):176-82. PubMed ID: 10636277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of acute hemodynamic effects of aerosolized iloprost and inhaled nitric oxide in adult congenital heart disease with severe pulmonary arterial hypertension.
    Caojin Z; Yigao H; Tao H; Wenhui H; Chunli X; Xinsheng H
    Intern Med; 2012; 51(20):2857-62. PubMed ID: 23064558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled nitric oxide versus aerosolized iloprost for the treatment of pulmonary hypertension with left heart disease.
    Yin N; Kaestle S; Yin J; Hentschel T; Pries AR; Kuppe H; Kuebler WM
    Crit Care Med; 2009 Mar; 37(3):980-6. PubMed ID: 19237907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjunct therapies during mechanical ventilation: airway clearance techniques, therapeutic aerosols, and gases.
    Kallet RH
    Respir Care; 2013 Jun; 58(6):1053-73. PubMed ID: 23709200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of inhaled versus intravenous vasodilators in experimental pulmonary hypertension.
    Walmrath D; Schermuly R; Pilch J; Grimminger F; Seeger W
    Eur Respir J; 1997 May; 10(5):1084-92. PubMed ID: 9163651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of aerosolized prostacyclin and inhaled nitric oxide on experimental hypoxic pulmonary hypertension.
    Max M; Kuhlen R; Dembinski R; Rossaint R
    Intensive Care Med; 1999 Oct; 25(10):1147-54. PubMed ID: 10551974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aerosolized prostacyclin and inhaled nitric oxide in septic shock--different effects on splanchnic oxygenation?
    Eichelbrönner O; Reinelt H; Wiedeck H; Mezödy M; Rossaint R; Georgieff M; Radermacher P
    Intensive Care Med; 1996 Sep; 22(9):880-7. PubMed ID: 8905421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiopulmonary effects of aerosolized prostaglandin E1 and nitric oxide inhalation in patients with acute respiratory distress syndrome.
    Putensen C; Hörmann C; Kleinsasser A; Putensen-Himmer G
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1743-7. PubMed ID: 9620900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic and oxygenation changes of combined therapy with inhaled nitric oxide and inhaled aerosolized prostacyclin.
    Rocca GD; Coccia C; Pompei L; Ruberto F; Venuta F; De Giacomo T; Pietropaoli P
    J Cardiothorac Vasc Anesth; 2001 Apr; 15(2):224-7. PubMed ID: 11312484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms.
    Rimensberger PC; Spahr-Schopfer I; Berner M; Jaeggi E; Kalangos A; Friedli B; Beghetti M
    Circulation; 2001 Jan; 103(4):544-8. PubMed ID: 11157720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled aerosolized prostacyclin and nitric oxide as selective pulmonary vasodilators in ARDS--a pilot study.
    Van Heerden PV; Blythe D; Webb SA
    Anaesth Intensive Care; 1996 Oct; 24(5):564-8. PubMed ID: 8909667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic effects of inhaled aerosolized iloprost and inhaled nitric oxide in heart transplant candidates with elevated pulmonary vascular resistance.
    Sablotzki A; Hentschel T; Gruenig E; Schubert S; Friedrich I; Mühling J; Dehne MG; Czeslick E
    Eur J Cardiothorac Surg; 2002 Nov; 22(5):746-52. PubMed ID: 12414041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhaled vasodilators].
    Zwissler B
    Anaesthesist; 2002 Aug; 51(8):603-24. PubMed ID: 12391520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of Inhaled Pulmonary Vasodilators to the Mechanically Ventilated Neonatal Patient.
    Davis MD; Donn SM; Ward RM
    Paediatr Drugs; 2017 Jun; 19(3):183-192. PubMed ID: 28374138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.